601 P200 V. 2014 Hardener

Hazard statements (CLP)

H304, H314, H317, H335, H412

Code

Statements

H304

May be fatal if swallowed and enters airways

SECTION 2: Hazards identification

OSHA Acute Oral Toxicity, Category 2 Skin Corrosion, Category 1C Serious Eye Damage, Category 2A

Aspiration hazard

Category 1

Signal word

Danger

Hazardous Ingredients

Homopolymer of Hexamethylene Diisocyanate

Hazard statements

H317 May cause an allergic skin reaction H304 May be fatal if swallowed and enters airways H412 Harmful to aquatic life with long lasting effects H335 May cause respiratory irritation H314 Causes severe skin burns and eye damage

Precautionary statements

P273 Avoid Release to the Environment P280 Wear protective gloves/ protective clothing/eye protection/face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do so. Continue Rinsing. P310 Immediately Call a POISON CENTER or doctor/physician. NFPA CODES

HMIS® ratings

Health : 2* 1 Flammability : 1 Reactivity : 1 2 1 Personal Protection : X

Health hazards

N/A

Potential health effects

SKIN Acute Causes irritation with symptoms of reddening, itching, and swelling. Can cause sensitization. Persons previously sensitized can experience allergic skin reaction with symptoms of reddening, itching, swelling, and rash. Cured material is difficult to remove. Chronic: Prolonged contact can cause reddening, swelling, rash, and, in some cases, skin sensitization. Animal tests and other research indicate that skin contact with diisocyanates can play a role in causing isocyanate sensitization and respiratory reaction. This data reinforces the need to prevent direct skin contact with isocyanates. EYES: Causes irritation with symptoms of reddening, tearing, stinging, and swelling. May cause temporary corneal injury. Vapor may cause irritation with symptoms of burning and tearing. Prolonged vapor contact may cause conjunctivitis. INHALATION Acute Diisocyanate or polyisocyanate vapors or mist at concentrations above the exposure limits or guidelines can irritate (burning sensation) the mucous membranes in the respiratory tract (nose, throat, lungs) with symptoms of runny nose, sore throat, coughing, chest discomfort, shortness of breath and reduced lung function (breathing difficulty). Persons with a preexisting, nonspecific bronchial hyperreactivity can respond to concentrations below the exposure limits or guidelines with similar symptoms as well as asthma attack or asthma-like symptoms. Exposure well above the exposure limits or guidelines may lead to bronchitis, bronchial spasm and pulmonary edema (fluid in lungs). Chemical or hypersensitivity pneumonitis, with flu- like symptoms (e.g. fever, chills), has also been reported. These symptoms can be delayed up to several hours after exposure. These effects are usually reversible. Chronic: As a result of previous repeated overexposures or a single large dose, certain individuals may develop sensitization to diisocyanates or polyisocyanates (asthma or asthma-like symptoms) that may cause them to react to a later exposure to diisocyanates or polyisocyanates at levels well below the exposure limits or guidelines. These symptoms, which can include chest tightness, wheezing, cough, shortness of breath or asthmatic attack, could be delayed up to several hours after exposure. Extreme asthmatic reactions can be life threatening. Similar to many non-specific asthmatic responses, there are reports that once sensitized an individual can experience these symptoms upon exposure to dust, cold air, or other irritants. This increased lung sensitivity can persist for weeks and in severe cases for several years. Sensitization can be permanent. Chronic overexposure to diisocyanates has also been reported to cause lung damage (including fibrosis, decrease in lung function) that may be permanent. INGESTION: May cause irritation; Symptoms may include abdominal pain, nausea, vomiting, and diarrhea. CHRONIC HAZARDS: No Carcinogenic substances as defined by IARC, NTP and/or OSHA. Medical conditions aggravated by exposure include: skin allergies, eczema, asthma, and respiratory disorders.